Navigation Links
Actavis' NDA for Progestin-Only Patch Accepted for Filing by FDA
Date:5/13/2013

Over-the-Counter (OTC) products in more than 60 countries.  Actavis Specialty Brands is the Company's global branded specialty pharmaceutical business focused in the Urology and Women's Health therapeutic categories.  Actavis Specialty Brands also has a portfolio of 5 biosimilar products in development in Women's Health and Oncology.

For press release and other company information, visit Actavis' Web site at http://www.actavis.com.

Forward-Looking Statement Statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Actavis' current perspective of existing trends and information as of the date of this release. Except as expressly required by law, Actavis disclaims any intent or obligation to update these forward-looking statements. Actual results may differ materially from Actavis' current expectations depending upon a number of factors affecting Actavis' business. These factors include, among others, the difficulty of predicting the timing or outcome of FDA approvals or actions, if any; the impact of competitive products and pricing; market acceptance of and continued demand for Actavis' products, ; difficulties or delays in manufacturing; and other risks and uncertainties detailed in Actavis' periodic public filings with the Securities and Exchange Commission, including but not limited to Actavis' Quarterly Report on Form 10-Q for the quarter ended March 31, 2013 and  Actavis' Annual Report on Form 10-K for the year ended December 31, 2012.  Except as expressly required by law, Actavis disclaims any intent or obligation to update these forward-looking statements.CONTACTS: Investors:Lisa DeFrancesco (862) 261-7152Media:Charlie Mayr(862) 261-8030(Logo: http://photos.prnewswire.com/prnh/20130124/NY47381LOGO )

 


'/>"/>
SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Actavis Cancels Presentation at Bank of America Merrill Lynch Healthcare Conference
2. Actavis Confirms Early Stage Discussions Regarding Potential Combination with Warner Chilcott plc
3. Actavis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
4. Actavis First Quarter 2013 Net Revenue Increases 24% to $1.9 Billion
5. Actavis Acquires Worldwide Rights for Valeants Metronidazole 1.3% Vaginal Gel
6. Actavis, Inc. to Host First Quarter 2013 Earnings Conference Call and Webcast
7. Former Clinton Deputy Solicitor General sheds light on flaws in Federal Trade Commissions case in FTC v. Actavis Inc.
8. Actavis, Inc. to Present at the Barclays 2013 Global Healthcare Conference
9. Actavis, Inc. to Present at the Cowen & Company 33rd Annual Health Care Conference
10. Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
11. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)...  EHE International, the recognized leader in preventive medicine ... today announced that Dignity Health Medical Group Nevada, LLC  ... been named an EHE-certified preventive care center. Through Dignity, ... region now have greater access to EHE,s preventive ... "EHE is proud to add Dignity Health ...
(Date:7/21/2014)... 21, 2014 According ... Research "E-Clinical Solution Software Market- Global Industry Analysis, Size, ... global microfluidic device market was valued at USD 3,005 ... a CAGR of 13.8% from 2014 to 2020, to ... 2020. Browse the full E-Clinical Solution Software Market ...
(Date:7/21/2014)... -- By order of the U.S. Bankruptcy Court, Tiger Group,s ... and optical equipment, designer eyeglass frames, and other assets of ... Services LLC. Online bidding opens July 21 at ... auction style, on July 28 beginning at 10:30 a.m. (ET). ... July 25 th and 26 th at 12 ...
Breaking Medicine Technology:EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 3E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 4E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 5Auction Set For Assets Of National Optical Services Company 2
... CAESAREA, Israel, May 2, 2012 Angioslide ... announced that it has received FDA 510(K) clearance for ... Disease in below the knee (BTK) vasculature.  The new ... potential use of PROTEUS technology.   Angioslide,s ...
... NBIX ) today announced its financial results for ... of 2012, the Company reported net loss of $0.9 million, ... of $2.9 million, or $0.05 income per share, for the ... results is primarily due to the Company,s VMAT2 program moving ...
Cached Medicine Technology:Angioslide Announces FDA 510(K) Clearance of PROTEUS(TM) Below The Knee Device 2Neurocrine Biosciences Reports First Quarter 2012 Results 2Neurocrine Biosciences Reports First Quarter 2012 Results 3Neurocrine Biosciences Reports First Quarter 2012 Results 4Neurocrine Biosciences Reports First Quarter 2012 Results 5Neurocrine Biosciences Reports First Quarter 2012 Results 6
(Date:7/21/2014)... that HIV and its monkey equivalent, SIV, gain a ... making it difficult to completely eliminate the virus even ... report that SIV can become entrenched in tissues fewer ... detectable in blood plasma (the liquid part) or blood ... Ph.D., of Beth Israel Deaconess Medical Center and the ...
(Date:7/21/2014)... CA (PRWEB) July 21, 2014 Ticket Down ... Manchester United tickets at the Rose Bowl . One of ... will be taking part in the 2014 Guinness International Champions Cup, ... The popular member of the English Premier League will get a ... travel to the Rose Bowl in Pasadena, Calif. for the Chevrolet ...
(Date:7/21/2014)... July 21, 2014 The New ... mesh lawsuits ( http://www.transvaginalmeshlawsuithelp.com/ ) filed against ... awarded last year to the Plaintiff in the ... Judge Carol Higbee of Atlantic County Superior Court ... judgment notwithstanding the verdict on July 15th, noting ...
(Date:7/21/2014)... July 21, 2014 (HealthDay News) -- A recently developed molecular ... in the lab. The team of scientists at Temple ... one day lead to a permanent treatment for HIV. They ... a vaccine to offer protection against the disease in the ... system, removal of the virus is required in order to ...
(Date:7/21/2014)... By Dennis Thompson ... (HealthDay News) -- Despite recent advances in preventing heart ... have occurred among middle-aged adults -- especially women, a ... young and middle-aged adults have remained stable during the ... a better than 20 percent decline in heart attacks, ...
Breaking Medicine News(10 mins):Health News:NIH-supported scientists demonstrate very early formation of SIV reservoir 2Health News:LA Galaxy vs. Manchester United Tickets Rose Bowl: Ticket Down Cuts Chevrolet FC Cup Ticket Prices For ManU vs. LA Galaxy in Pasadena on July 23rd 2Health News:LA Galaxy vs. Manchester United Tickets Rose Bowl: Ticket Down Cuts Chevrolet FC Cup Ticket Prices For ManU vs. LA Galaxy in Pasadena on July 23rd 3Health News:Court Overseeing First Ethicon Transvaginal Mesh Lawsuit Trial in New Jersey Upholds $11 Million+ Jury Award, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing First Ethicon Transvaginal Mesh Lawsuit Trial in New Jersey Upholds $11 Million+ Jury Award, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing First Ethicon Transvaginal Mesh Lawsuit Trial in New Jersey Upholds $11 Million+ Jury Award, Bernstein Liebhard LLP Reports 4Health News:Scientists Snipped HIV Out of Human DNA 2Health News:No Change in Heart Attack Rates for Younger U.S. Adults 2Health News:No Change in Heart Attack Rates for Younger U.S. Adults 3
... of Medicine apparently have solved the riddle of why cancer ... mechanism that could lead to better cancer treatments. , ... laboratory in the Duke Department of Pharmacology and Cancer Biology, ... a way to avoid programmed cell death. They make use ...
... Alcon, Inc.,(NYSE: ACL ) announced today that ... PATANASE(R) (olopatadine hydrochloride) nasal spray for,the relief of ... 12,years of age and older. PATANASE(R) nasal spray, ... will be available in May of,this year., ...
... As the State of Nebraska,s Chief,Medical Officer, Joann ... health issues. The same goes for Gary Gorby, ... Medical Center. Right now, both,physicians are focusing on ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080415/LATU118LOGO ), Dr. Schaefer, 40, ...
... Gift of Mobility Helps Teenager Attend Classes and Take ... Like many,15-year-olds, Rachel Wilhite enjoys hanging out with ... However, she is also struggling with a condition that ... relatively rare dwarfism that,has serious consequences. When the body ...
... Advertising and Medical Education ... Network, ... more than 15 years strategic and business-building,experience, has joined GHG Grey Healthcare ... Grey,Healthcare Group (GHG) is a WPP company and one of the world,s ...
... NEW YORK, April 15 GHG Grey Healthcare ... world,s leading healthcare communications firms,announced that Jennifer Samuels ... Services. Ms. Samuels has a wide range of ... industry, and an in-depth,knowledge of the oncology and ...
Cached Medicine News:Health News:A potential sugar fix for tumors 2Health News:Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms 2Health News:Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms 3Health News:Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms 4Health News:Two Prominent Nebraska Doctors Become Patients in Living Donor Liver Transplant 2Health News:Two Prominent Nebraska Doctors Become Patients in Living Donor Liver Transplant 3Health News:Two Prominent Nebraska Doctors Become Patients in Living Donor Liver Transplant 4Health News:The SCOOTER Store Donates Power Chair to Teenager Struggling With Rare Dwarfism 2Health News:The SCOOTER Store Donates Power Chair to Teenager Struggling With Rare Dwarfism 3Health News:Susan Byrne joins GHG Grey Healthcare Group as EVP, Strategy and Business Development, Europe, a Newly-Created Position 2Health News:Jennifer Samuels Joins GHG Grey Healthcare Group as Executive Vice President, Account Services 2
Bioceramic orbital implants insert easily into orbital socket and will not cling to surrounding tissue. Improved interconnectivity between pores enhances vascularization. Implants may be easily drill...
Designed for the clockwise one-hand implantation of the Morcher Capsular Tension Ring....
... the Diagnosys electrophysiology system is the Espion. This ... support a wide variety of stimulators for different ... Function Testing ,The Espion system was designed ... the current standard clinical visual function tests, ERG, ...
... the heart of the Espion2 Electrophysiology system. ... aluminum chassis, real-time DSP, USB control, an ... differential amplifiers. The E2 connects to any ... over standard wi-fi Ethernet. The E2 includes ...
Medicine Products: